Similar articles

• [Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?].

  Sudhop T, von Bergmann K. Sudhop T, et al. MMW Fortschr Med. 2003 May 22;145(21):19. MMW Fortschr Med. 2003. PMID: 12845862 German. No abstract available.
• [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2005 Aug 18;147(33-34):50-1. MMW Fortschr Med. 2005. PMID: 16138640 German. No abstract available.
• [How can lipid therapy be improved? Cardiologists insist on dual cholesterol inhibition].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2005 Nov 10;147(45):54. MMW Fortschr Med. 2005. PMID: 16320655 German. No abstract available.
• [LDL cholesterol in normal range. The lower the better? Implications of the GREACE study].

  März W. März W. MMW Fortschr Med. 2003 Dec 11;145(50):46-9. MMW Fortschr Med. 2003. PMID: 14963971 Review. German.
• [Substantiation of increasing doses of statins in clinical practice].

  Susekov AV. Susekov AV. Ter Arkh. 2001;73(4):76-80. Ter Arkh. 2001. PMID: 11494456 Review. Russian. No abstract available.